234 related articles for article (PubMed ID: 30850732)
1. TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma.
Podder B; Guttà C; Rožanc J; Gerlach E; Feoktistova M; Panayotova-Dimitrova D; Alexopoulos LG; Leverkus M; Rehm M
Cell Death Differ; 2019 Dec; 26(12):2520-2534. PubMed ID: 30850732
[TBL] [Abstract][Full Text] [Related]
2. RIPK3 contributes to TNFR1-mediated RIPK1 kinase-dependent apoptosis in conditions of cIAP1/2 depletion or TAK1 kinase inhibition.
Dondelinger Y; Aguileta MA; Goossens V; Dubuisson C; Grootjans S; Dejardin E; Vandenabeele P; Bertrand MJ
Cell Death Differ; 2013 Oct; 20(10):1381-92. PubMed ID: 23892367
[TBL] [Abstract][Full Text] [Related]
3. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
Geng J; Ito Y; Shi L; Amin P; Chu J; Ouchida AT; Mookhtiar AK; Zhao H; Xu D; Shan B; Najafov A; Gao G; Akira S; Yuan J
Nat Commun; 2017 Aug; 8(1):359. PubMed ID: 28842570
[TBL] [Abstract][Full Text] [Related]
4. The neurotoxicant PCB-95 by increasing the neuronal transcriptional repressor REST down-regulates caspase-8 and increases Ripk1, Ripk3 and MLKL expression determining necroptotic neuronal death.
Guida N; Laudati G; Serani A; Mascolo L; Molinaro P; Montuori P; Di Renzo G; Canzoniero LMT; Formisano L
Biochem Pharmacol; 2017 Oct; 142():229-241. PubMed ID: 28676433
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-specific TAK1 deficiency drives RIPK1 kinase-dependent inflammation to promote liver fibrosis and hepatocellular carcinoma.
Tan S; Zhao J; Sun Z; Cao S; Niu K; Zhong Y; Wang H; Shi L; Pan H; Hu J; Qian L; Liu N; Yuan J
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14231-14242. PubMed ID: 32513687
[TBL] [Abstract][Full Text] [Related]
6. TAK1 regulates endothelial cell necroptosis and tumor metastasis.
Yang L; Joseph S; Sun T; Hoffmann J; Thevissen S; Offermanns S; Strilic B
Cell Death Differ; 2019 Oct; 26(10):1987-1997. PubMed ID: 30683914
[TBL] [Abstract][Full Text] [Related]
7. A cellular screen identifies ponatinib and pazopanib as inhibitors of necroptosis.
Fauster A; Rebsamen M; Huber KV; Bigenzahn JW; Stukalov A; Lardeau CH; Scorzoni S; Bruckner M; Gridling M; Parapatics K; Colinge J; Bennett KL; Kubicek S; Krautwald S; Linkermann A; Superti-Furga G
Cell Death Dis; 2015 May; 6(5):e1767. PubMed ID: 25996294
[TBL] [Abstract][Full Text] [Related]
8. Mechanism and in vitro pharmacology of TAK1 inhibition by (5Z)-7-Oxozeaenol.
Wu J; Powell F; Larsen NA; Lai Z; Byth KF; Read J; Gu RF; Roth M; Toader D; Saeh JC; Chen H
ACS Chem Biol; 2013 Mar; 8(3):643-50. PubMed ID: 23272696
[TBL] [Abstract][Full Text] [Related]
9. Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
Lomphithak T; Choksi S; Mutirangura A; Tohtong R; Tencomnao T; Usubuchi H; Unno M; Sasano H; Jitkaew S
Cell Commun Signal; 2020 Oct; 18(1):161. PubMed ID: 33036630
[TBL] [Abstract][Full Text] [Related]
10. RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury.
Krishna-Subramanian S; Singer S; Armaka M; Banales JM; Holzer K; Schirmacher P; Walczak H; Kollias G; Pasparakis M; Kondylis V
Cell Death Differ; 2019 Dec; 26(12):2710-2726. PubMed ID: 30988397
[TBL] [Abstract][Full Text] [Related]
11. The protein phosphatase PP6 promotes RIPK1-dependent PANoptosis.
Bynigeri RR; Malireddi RKS; Mall R; Connelly JP; Pruett-Miller SM; Kanneganti TD
BMC Biol; 2024 May; 22(1):122. PubMed ID: 38807188
[TBL] [Abstract][Full Text] [Related]
12. Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease.
Malireddi RKS; Gurung P; Kesavardhana S; Samir P; Burton A; Mummareddy H; Vogel P; Pelletier S; Burgula S; Kanneganti TD
J Exp Med; 2020 Mar; 217(3):. PubMed ID: 31869420
[TBL] [Abstract][Full Text] [Related]
13. The E3 Ubiquitin-Protein Ligase RNF4 Promotes TNF-α-Induced Cell Death Triggered by RIPK1.
Shimada T; Kudoh Y; Noguchi T; Kagi T; Suzuki M; Tsuchida M; Komatsu H; Takahashi M; Hirata Y; Matsuzawa A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071450
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of TAK1 aggravates airway inflammation by increasing RIPK1 activity and promoting macrophage death in a mouse model of toluene diisocyanate-induced asthma].
Yang S; Zhao W; Peng X; Lan Z; Huang J; Han H; Chen Y; Cai S; Zhao H
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Feb; 42(2):181-189. PubMed ID: 35365441
[TBL] [Abstract][Full Text] [Related]
15. ABIN-1 is a key regulator in RIPK1-dependent apoptosis (RDA) and necroptosis, and ABIN-1 deficiency potentiates necroptosis-based cancer therapy in colorectal cancer.
Cai J; Hu D; Sakya J; Sun T; Wang D; Wang L; Mao X; Su Z
Cell Death Dis; 2021 Feb; 12(2):140. PubMed ID: 33542218
[TBL] [Abstract][Full Text] [Related]
16. Opposite Effects of Apoptotic and Necroptotic Cellular Pathways on Rotavirus Replication.
Soliman M; Seo JY; Baek YB; Park JG; Kang MI; Cho KO; Park SI
J Virol; 2022 Jan; 96(1):e0122221. PubMed ID: 34668777
[TBL] [Abstract][Full Text] [Related]
17. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase.
Ninomiya-Tsuji J; Kajino T; Ono K; Ohtomo T; Matsumoto M; Shiina M; Mihara M; Tsuchiya M; Matsumoto K
J Biol Chem; 2003 May; 278(20):18485-90. PubMed ID: 12624112
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of PPP6C protects TNF-induced necroptosis through activation of TAK1.
Zou Y; Zheng Q; Jiang B; Liu Y; Xu Y; Ma L; Hu Z; Wu M; Song H
Cell Death Dis; 2022 Jul; 13(7):618. PubMed ID: 35842423
[TBL] [Abstract][Full Text] [Related]
19. Protein-Bound Polysaccharides from
Pawlikowska M; Jędrzejewski T; Brożyna AA; Wrotek S
Cell Physiol Biochem; 2020 Jun; 54(4):591-604. PubMed ID: 32531147
[TBL] [Abstract][Full Text] [Related]
20. Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells.
Hrabe JE; O'Leary BR; Fath MA; Rodman SN; Button AM; Domann FE; Spitz DR; Mezhir JJ
Redox Biol; 2015 Aug; 5():319-327. PubMed ID: 26114584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
